Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Isabel Zapico, Laura Cabiedes & Teresa Iglesias. (2016) Patient access to new oncology medicines in the Spanish hospital setting: exploring explanatory factors through a Cox regression model. Expert Review of Quality of Life in Cancer Care 1:3, pages 249-255.
Read now
Read now
Articles from other publishers (8)
Luís Costa, Teresa Alexandre, André Mansinho, Rita Sousa, Cláudia Vieira, Robert Hughes, Alexander Roediger, Sónia Matos Pereira & António Araújo. (2023) Health outcomes and budget impact projection of anti-PD-(L)1s in cancer care in Portugal. Frontiers in Public Health 11.
Crossref
Crossref
Rositsa Koleva-Kolarova, James Buchanan, Heleen Vellekoop, Simone Huygens, Matthijs Versteegh, Maureen Rutten-van Mölken, László Szilberhorn, Tamás Zelei, Balázs Nagy, Sarah Wordsworth & Apostolos Tsiachristas. (2022) Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options. Applied Health Economics and Health Policy 20:4, pages 501-524.
Crossref
Crossref
Daanish Hoda, Robert Richards, Edward A Faber, Abhinav Deol, Bradley D Hunter, Elizabeth Weber, Heather DiFilippo, Toni Henderson-Clark, Linda Meaux, Concetta Crivera, Carrie Riccobono, Ashraf Garrett, Carolyn C Jackson, Jessica Fowler, Panteli Theocharous, Raj Stewart, Andrea L Lorden, David L Porter & Ariel Berger. (2022) Process, resource and success factors associated with chimeric antigen receptor T-cell therapy for multiple myeloma. Future Oncology 18:19, pages 2415-2431.
Crossref
Crossref
So-Young Ha, Dong-Won Kang, Hye-In Jung, Eui-Kyung Lee & Mi-Hai Park. (2022) Value-Based Pricing and Budget Impact Analysis for Multi-Indication Drugs: A Case Study of Immunotherapies. International Journal of Environmental Research and Public Health 19:7, pages 4105.
Crossref
Crossref
Dominic Adam Worku & Victoria Hewitt. (2020) The role and economics of immunotherapy in solid tumour management. Journal of Oncology Pharmacy Practice 26:8, pages 2020-2024.
Crossref
Crossref
D. Dankó, J-Y. Blay & L.P. Garrison. (2019) Challenges in the value assessment, pricing and funding of targeted combination therapies in oncology. Health Policy 123:12, pages 1230-1236.
Crossref
Crossref
Pia Osterlund, Halfdan Sorbye, Per Pfeiffer, Anders Johnsson, Filipe Rodrigues & Gianluca Furneri. (2016) Drug costs and benefits of medical treatments in high-unmet need solid tumours in the Nordic countries. Journal of Cancer Policy 7, pages 12-22.
Crossref
Crossref
Laura E. Strong. (2015) The Past, Present, and Future of Patient-Reported Outcomes in Oncology. American Society of Clinical Oncology Educational Book:35, pages e616-e620.
Crossref
Crossref